Tzu-Yu Lin, Cheng-Wei Lu, Su-Jane Wang
Index: Neurochem. Int. 54(8) , 526-34, (2009)
Full Text: HTML
Dextromethorphan (DM), a widely used antitussive, has demonstrated an effective neuroprotective effect. Excessive release of glutamate is considered to be an underlying cause of neuronal damage in several neurological diseases. In the present study, we investigated whether DM or its metabolite 3-hydroxymorphinan (3-HM) could affect glutamate release in rat cerebral cortex nerve terminals (synaptosomes). DM or 3-HM inhibited the Ca(2+)-dependent release of glutamate that was evoked by exposing synaptosomes to the K(+) channel blocker 4-aminopyridine (4-AP), and this presynaptic inhibition was concentration-dependent. Inhibition of glutamate release by DM or 3-HM was resulted from a reduction of vesicular exocytosis, because the vesicular transporter inhibitor bafilomycin A1 completely blocked DM or 3-HM-mediated inhibition of 4-AP-evoked glutamate release. DM or 3-HM did not alter the resting synaptosomal membrane potential or 4-AP-mediated depolarization, but significantly reduced depolarization-induced increase in [Ca(2+)](C). DM or 3-HM-mediated inhibition of 4-AP-evoked glutamate release was blocked by omega-conotoxin MVIIC, an antagonist of N- and P/Q-type Ca(2+) channel, not by dantrolene, an intracellular Ca(2+) release inhibitor. DM or 3-HM modulation of 4-AP-evoked glutamate release appeared to involve a protein kinase C (PKC) signaling cascade, insofar as pretreatment of synaptosomes with the PKC inhibitors GF109203X or Ro318220 all effectively occluded the inhibitory effect of DM or 3-HM. Furthermore, 4-AP-induced phosphorylation of PKC was reduced by DM or 3-HM. These results suggest that DM or 3-HM inhibits glutamate release from rat cortical synaptosomes through the suppression of presynaptic voltage-dependent Ca(2+) entry and PKC activity. This may explain the neuroprotective effects of DM against neurotoxicity.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
(+)-3-HYDROXYMORPHINAN HYDROBROMIDE
CAS:15676-23-0 |
C16H21NO |
A validated SIM GC/MS method for the simultaneous determinat...
2009-11-01 [Biomed. Chromatogr. 23(11) , 1131-7, (2009)] |
Simultaneous quantification of dextromethorphan and its meta...
2011-01-25 [J. Pharm. Biomed. Anal. 54(2) , 387-94, (2011)] |
Validation of a liquid chromatography-mass spectrometry meth...
2005-05-05 [J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 819(1) , 105-13, (2005)] |
New morphinan derivatives with negligible psychotropic effec...
2003-03-07 [Life Sci. 72(16) , 1883-95, (2003)] |
Metabolism of dextrorphan by CYP2D6 in different recombinant...
2009-02-01 [J. Pharm. Sci. 98(2) , 763-71, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved